SXTP 60 Degrees Pharmaceuticals, Inc.
60 Degrees Pharmaceuticals, Inc. (SXTP) is expected to report earnings on November 13, 2026, during market hours. The consensus earnings estimate is a loss of $0.73 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -10.9% since its last earnings release on August 14, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About 60 Degrees Pharmaceuticals, Inc.
60 Degrees Pharmaceuticals Inc. specializes in developing and marketing new medicines for the treatment and prevention of infectious diseases. 60 Degrees Pharmaceuticals Inc. is based in WASHINGTON.
Sector
Healthcare
Industry
Drug Manufacturers/Other